Wb. Chan et al., Glycaemic control in type 2 diabetes: the impact of body weight, beta-cellfunction and patient education, QJM-MON J A, 93(3), 2000, pp. 183-190
Citations number
58
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Journal title
QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
We examined the determinants of glycaemic control in a consecutive cohort o
f 562 newly-referred Chinese type 2 diabetic patients (57% women) during a
12-month period. All patients underwent a structured assessment with docume
ntation of clinical and biochemical characteristics. Pancreatic beta-cell f
unction was assessed by fasting plasma C-peptide concentration. Insulin def
iciency was defined as fasting plasma C-peptide < 0.2 pmol/ml. Insulin resi
stance (IR) was calculated using the homeostasis moder assessment (HOMA) ba
sed on a product of fasting plasma glucose and insulin concentrations. Trea
tment was considered appropriate when insulin-deficient patients were treat
ed with insulin and non-insulin-deficient patients were treated with oral a
gents or diet. Mean (+/-SD) age was 54.3 +/- 13.8 years (range 17-87 years)
and disease duration was 5.0 +/- 5.9 years. At the time of referral, 70.5%
(n = 396) were on drug therapy (9% on insulin and 62.8% on oral agents), 2
0.6% (n = 116) were on diet and 9% (n = 50) had not received any form of tr
eatment. The mean HbA(Ic) was 8.4 +/- 2.3%. The geometric mean ( x / divide
d by antilog SD) of IR was 4.62 x / divided by 2.51 (range 0.63-162.7) and
correlated only with waist:hip ratio (WHR, p = 0.008). The geometric mean o
f plasma C peptide was 0.47 x / divided by 2.89 nmol/l and correlated with
BMI (p < 0.001). Glycated haemoglobin was correlated positively with age (p
= 0.013), disease duration (p < 0.001), IR (p < 0.001) and negatively with
EMI (p < 0.001). Glycated haemoglobin was lower in patients who had seen a
dietitian (7.9% vs. 8.7%, p < 0.001) or diabetes nurse (7.8% vs. 8.7%, p <
0.001) or who performed self blood glucose monitoring (7.9% vs. 8.6%, p =
0.001) and higher among smokers (8.9% vs. 8.2%, p = 0.003). Compared to ins
ulin-deficient patients (n = 118), non-insulin-deficient patients (n=413) h
ad features resembling that of the Metabolic Syndrome with increased WHR (p
= 0.005), brood pressure (p < 0.001), BMI (p = 0.001) and were order (p =
0.04). Amongst the insulin-deficient patients, 27% were treated with oral a
gents or diet. Patients receiving appropriate therapy (n = 362) had a lower
HbA(Ic) than those treated inappropriately (n = 173) (8.2% vs. 8.7%, p = 0
.02). On multivariate analysis, short disease duration (p < 0.001), row IR
(p < 0.001), high BMI (p = 0.001), diabetes education (p < 0.001), rack of
smoking (p = 0.014) and choice of appropriate treatment (p = 0.009) were th
e independent determinants of good glycaemic control.